StockMarketWire.com - JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC [LON:GSK] and cut its price target to 1750p (from 1900p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk